GlaxoSmithKline announces reduction in the investment into treatments for pain and depression

Download PDF Copy

Feb 5 2010

NewsGuard 100/100 Score

GlaxoSmithKline today said it had posted a strong performance in a challenging year with a return to sales growth for the first time since 2007.

In an interview on http://www.cantos.com CEO Andrew Witty also announced a reduction in the investment into treatments for pain and depression and a restructuring of R&D.

He said:

"Now obviously I don't like to see anybody leave the organisation or there to be any job losses. But the reality is that we do, from time to time, need to look at ways in which we can improve our probability of success."

SOURCE GlaxoSmithKline

Posted in:

Tags: Depression, GlaxoSmithKline, Mental Health, Pain

Comments (0)

Download PDF Copy

Suggested Reading

New study links circadian gene variants to winter depression

New study links circadian gene variants to winter depression

Iron and vitamin D reduce depression risk, while selenium and magnesium raise it

Iron and vitamin D reduce depression risk, while selenium and magnesium raise it

Maternal stress and depression alter infant DNA, with potential lifelong impact

Maternal stress and depression alter infant DNA, with potential lifelong impact

Low vitamin D associated with increased depression risk in pregnancy and after birth

Low vitamin D associated with increased depression risk in pregnancy and after birth

Study suggests beta-blockers may elevate depression symptoms in post-MI patients

Study suggests beta-blockers may elevate depression symptoms in post-MI patients

Research highlights immune system's role in depression

Research highlights immune system's role in depression

Unraveling the psychological impact of COVID-19 on young minds

Unraveling the psychological impact of COVID-19 on young minds

Childhood neglect linked with mental and physical health problems in adulthood

Childhood neglect linked with mental and physical health problems in adulthood

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Age, education, and religion impact depression risk among Nigerian older adults